NEWS
New Feature!!!! University Subject Rankings in 12 branches
FOR SCIENTIST REGISTRATION FOR INSTITUTIONAL BULK REGISTRATION
FOR EDIT YOUR UNIVERSITY / INSTITUTION PAGE
Some differences of the AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
List without CERN, Statistical Data etc. Only in AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
AD
Scientific Index 2024
About Us
Methodology
Compare & Choose
Contact - FAQ
login
Login
person_add
Register
school
University Rankings
subject
University Subject Rankings
place
Country Rankings
insights
i10 Productivity Rankings
insights
Subject Rankings
format_list_numbered
Top 100 Scientists
format_list_numbered
Citation Rankings
format_quote
Top 100 Institutions
local_fire_department
Country Top Lists
Igor Smolenov
AD Scientific Index 2024
Medical and Health Sciences / Epidemiology and Public Health
Clover Biopharmaceuticals - / China
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Igor Smolenov's MOST POPULAR ARTICLES
1-)
mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials RA Feldman, R Fuhr, I Smolenov, AM Ribeiro, L Panther, M Watson, ... Vaccine 37 (25), 3326-3334, 2019 3232019
2-)
Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial P Richmond, L Hatchuel, M Dong, B Ma, B Hu, I Smolenov, P Li, P Liang, ... The lancet 397 (10275), 682-694, 2021 2092021
3-)
Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study KB Phua, FS Lim, YL Lau, EAS Nelson, LM Huang, SH Quak, BW Lee, ... Vaccine 27 (43), 5936-5941, 2009 1682009
4-)
Качество жизни у больных бронхиальной астмой и хронической обструктивной болезнью легкихАГ Чучалин, АС Белевский, ИВ Смоленов, НЮ СенкевичАтмосфера 56, 20041212004
5-)
A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adultsAO Aliprantis, CA Shaw, P Griffin, N Farinola, RA Railkar, X Cao, W Liu, ...Human vaccines & immunotherapeutics 17 (5), 1248-1261, 20211052021
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept